MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus

[ad_1] New investment from EQT Life Sciences and OrbiMed with participation from existing investors MinervaX will hold financial reserves of more than €125 million, following the financing The financing supports…

Ventia block upsized to $400m; Apollo dips below substantial holding

[ad_1] The float ended up being repriced to $1.70 a share, with Apollo and CIMIC retaining a combined 65 per cent of Ventia to a February 2023 escrow. While the…

NewAmsterdam Pharma Announces Pricing of Upsized Secondary Offering of Ordinary Shares

[ad_1] NAARDEN, The Netherlands and MIAMI, June 06, 2023 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a clinical-stage biopharmaceutical company developing oral, non-statin medicines…